Cme (CME) Liabilities and Shareholders Equity (2016 - 2025)
Historic Liabilities and Shareholders Equity for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $187.1 billion.
- Cme's Liabilities and Shareholders Equity rose 3581.37% to $187.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $662.3 billion, marking a year-over-year increase of 2665.65%. This contributed to the annual value of $137.4 billion for FY2024, which is 596.8% up from last year.
- According to the latest figures from Q3 2025, Cme's Liabilities and Shareholders Equity is $187.1 billion, which was up 3581.37% from $179.9 billion recorded in Q2 2025.
- In the past 5 years, Cme's Liabilities and Shareholders Equity registered a high of $205.9 billion during Q1 2022, and its lowest value of $123.4 billion during Q2 2024.
- Moreover, its 5-year median value for Liabilities and Shareholders Equity was $166.0 billion (2023), whereas its average is $162.4 billion.
- Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first surged by 5785.41% in 2021, then plummeted by 2960.99% in 2023.
- Over the past 5 years, Cme's Liabilities and Shareholders Equity (Quarter) stood at $196.8 billion in 2021, then fell by 11.49% to $174.2 billion in 2022, then dropped by 25.53% to $129.7 billion in 2023, then grew by 5.97% to $137.4 billion in 2024, then soared by 36.16% to $187.1 billion in 2025.
- Its Liabilities and Shareholders Equity was $187.1 billion in Q3 2025, compared to $179.9 billion in Q2 2025 and $157.8 billion in Q1 2025.